Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can text reminders and health coaches boost RSV shots in latino seniors?

NCT ID NCT07171164

Prevention Sponsor: University of California, San Francisco Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests whether community health worker counseling and text message reminders can increase RSV vaccination among Latino adults aged 50 and older in San Francisco and Daly City. Researchers will also see if younger adults can encourage their older friends and family to get vaccinated. The goal is to find simple, community-based ways to improve vaccine uptake and prevent severe RSV illness.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
community health worker counseling and text message reminders
What this could lead to
If successful, this could show a practical way to boost RSV vaccination rates in underserved communities, potentially preventing severe respiratory illness.
What could go wrong
This is a behavioral study, not a drug trial. Success depends on whether reminders and counseling actually change behavior, and results may not apply outside this specific community.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 750 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Nov 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Motivate Aim Inclusion Criteria: * Age 50 years or older * Self-identify as Latino/a/x and/or indigenous groups from Latin America * Eligible for RSV vaccination per current CDC/ACIP recommendations * Fluent in Spanish or English * Has not received the RSV vaccine * Has a cell phone * Lives or works in San Francisco or Daly City * Able to provide informed consent Motivate Aim Exclusion Criteria: * Intent to move outside of San Francisco or Daly City in the next year * Nursing home resident * Household member participating in Aim 1 or 2 * Unable to provide consent Motivate Aim Inclusion Criteria: * Age 18-49 years * Self-identify as Latino/a/x and/or indigenous groups from Latin America * Fluent in English or Spanish * Has \>1 family member or friend 50 years or older who they have seen or spoken to for \>15 minutes in the last 6 months and who lives in the United States Activate Trial Exclusion Criteria: * Household member enrolled in Aim 1 or 2 * Unable to provide consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Older adults without any specific clinical condition are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

respiratory syncytial virus infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Older adults without any specific clinical condition RSV immunization Social networks Vaccine uptake

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    1 site. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • University of California, San Francisco

    RECRUITING

    San Francisco, California, 94110, United States

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.